ImmunoCellular Therapeutics Ltd Alternatives & Competitors
12 companies similar to ImmunoCellular Therapeutics Ltd — Pioneering immune-based therapies to harness the body's defenses against cancer...
Companies similar to ImmunoCellular Therapeutics Ltd
Genenta Science (Nasdaq: GNTA)
Genenta is a clinical stage immuno-oncology company
Milan, Italy
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
TransCode Therapeutics, Inc.
Delivering a cancer-free future
Newton, United States
Enterome
Delivering the promise of immunotherapy
Paris, France
Track all ImmunoCellular Therapeutics Ltd competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
ImmunoGenesis, Inc.
Re-envisioning cold tumor treatment. Our deliberate drug development strategy targets mech...
Houston, United States
Trillium Therapeutics Inc.
Clinical stage immuno-oncology company developing innovative therapies for the treatment o...
Cambridge, United States
Xilio Therapeutics, Inc.
Focused on harnessing the immune system to achieve deep and durable clinical responses to...
Waltham, United States
NEOGAP Therapeutics AB
Science for cure.
Stockholm, Sweden
Kite Pharma
At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.
Santa Monica, United Stat...
Achilles Therapeutics plc
Personalised T cell therapies targeting clonal neoantigens
United Kingdom
OncoPep, Inc.
To develop and commercialize targeted immuno-therapeutics which prevent the progression of...
Boston, United States
3T Biosciences
3T is an immunotherapy company developing next-generation, transformative therapies for br...
South San Francisco, Unit...
About ImmunoCellular Therapeutics Ltd
ImmunoCellular Therapeutics is a biotechnology firm pioneering immune-based therapies to harness the body's defenses against cancer through advanced immunotherapy development. Founded in 2006, the company focuses on creating immune-based treatments for cancers. Its flagship product, ICT-107, is a dendritic cell (DC) im...
ImmunoCellular Therapeutics, Immune-based Therapies, Immunotherapy Development, Cancer Treatment, Clinical-stage, ICT-107, Dendritic Cell Immunotherapy, Glioblastoma Multiforme, Brain Cancer, Immune System Stimulation, Tumor Antigens, Immune Response, Cancer Immunotherapy, Patient-specific Treatment
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches ImmunoCellular Therapeutics Ltd and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at ImmunoCellular Therapeutics Ltd on 14 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 10 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
